CASP3 and gastric cancer: In line with this, biglycan was recently shown to modulate gastric cancer aggressive features as cell survival, migration, and angiogenesis and biglycan knockout gastric cancer cells showed increased levels of PARP1 (Poly [ADP-ribose] polymerase 1) and Caspase 3 cleavage (200).